Latitude Advisors, LLC Novartis Ag Transaction History

Latitude Advisors, LLC

$153 Million
Q3 2024

A detailed history of Latitude Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, Latitude Advisors, LLC holds 3,501 shares of NVS stock, worth $339,877. This represents 0.26% of its overall portfolio holdings.

Number of Shares

3,501

Previous 3,501 -0.0%

Holding current value

$339,877

Previous $372,000 8.06%

% of portfolio

0.26%

Previous 0.26%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	BUY	$92.57 - $107.37 $185 - $214	2 Added 0.06%	3,501 $372,000
Q1 2024 Apr 25, 2024	BUY	$95.27 - $108.47 $52,112 - $59,333	547 Added 18.53%	3,499 $338,000
Q1 2023 Apr 27, 2023	BUY	$80.03 - $92.81 $240 - $278	3 Added 0.1%	2,952 $271,000
Q4 2022 Jan 27, 2023	SELL	$75.55 - $92.52 $19,340 - $23,685	-256 Reduced 7.99%	2,949 $0
Q3 2022 Nov 01, 2022	SELL	$74.61 - $87.26 $149 - $174	-2 Reduced 0.06%	3,205 $244,000
Q2 2022 Jul 28, 2022	SELL	$80.52 - $93.75 $516,777 - $601,687	-6,418 Reduced 66.68%	3,207 $271,000
Q1 2022 Apr 29, 2022	BUY	$80.11 - $90.62 $222,385 - $251,561	2,776 Added 40.53%	9,625 $845,000
Q4 2021 Jan 18, 2022	SELL	$79.7 - $88.13 $38,574 - $42,654	-484 Reduced 6.6%	6,849 $599,000
Q3 2021 Oct 14, 2021	BUY	$81.78 - $95.14 $303,812 - $353,445	3,715 Added 102.68%	7,333 $600,000
Q2 2021 Jul 20, 2021	BUY	$85.24 - $94.15 $3,494 - $3,860	41 Added 1.15%	3,618 $330,000
Q1 2021 Apr 14, 2021	SELL	$83.5 - $98.47 $520,789 - $614,157	-6,237 Reduced 63.55%	3,577 $306,000
Q4 2020 Feb 04, 2021	BUY	$78.07 - $94.43 $766,178 - $926,736	9,814 New	9,814 $927,000

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $209B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Latitude Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Latitude Advisors, LLC with notifications on news.

Account

Latitude Advisors, LLC Novartis Ag Transaction History